The enrolment for phase III clinical trials of India's first dengue vaccine, DengiAll, is expected to be completed by October ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

Using a variety of models helps to ensure that the best research is being done to benefit patients and their families.

We don't have $3.8 billion to spend on the pursuit of cures for illness but we have $75 billion for the work of ICE? What a ...

Lawmakers probe University of Michigan for handling biological smuggling claims linked to Chinese researchers.

Columbia University is set to settle with the Trump administration over alleged civil rights violations, agreeing to pay ...

A University of Arizona cancer research lab, facing difficulties in getting federal funding, has started a crowdfunding ...

Lawrence O. Gostin discusses the importance of equity and science in the face of threats to global health security.

"I feel most proud of this (screening study), because I feel this could really move the field,” said Dr. Richard Frank.